Petra Zubor

Dr. Petra Zubor


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2026 in Nursing Reports
Verified
Journal Article
Open access
PDF file
PZPetra Zubor
Petra Zubor
ASAlica Slamkova
Alica Slamkova
MMMiloš Mlynček
Miloš Mlynček
JVJozef Visnovsky
Jozef Visnovsky
JBJan Bujnak
Jan Bujnak
Pavol ZuborPavol Zubor
Pavol Zubor
Objectives: This study sought to assess quality of life (QoL) in Slovak breast cancer survivors and examine its association with treatment modalities and sociodemographic factors. Methods: This cross-sectional observational study included 244 Slovak female breast cancer survivors (stages IA–IIIC). Participants were aged 25–85 years, ECOG 1–2, without synchronous malignancies or severe comorbidities. Data were collected using the EORTC QLQ-C30 and breast cancer-specific module. Results: Mean global health status/QoL indicated a moderate QoL level (51.67). Emotional and cognitive functioning were relatively preserved, whereas social and role functioning were more impaired. The most prominent symptoms included insomnia, fatigue, dyspnoea, and pain. Breast cancer-specific domains showed relatively high body image scores but marked impairment in sexual activity and future perspective. Severe symptoms included hair loss, upper limb problems and systemic side effects of therapy. Significant differences were observed across functional domains and symptoms (p < 0.001). Chemotherapy was associated with better role functioning (p = 0.011), lower pain (p = 0.043) and insomnia (p = 0.012), but also with higher levels of hair loss (p = 0.003); however, these findings should be interpreted with caution due to potential confounding factors. Radiotherapy was associated with higher social functioning, body image and future perspective (p = 0.007 for all), but also with increased breast symptom severity (p = 0.044). Sociodemographic factors, particularly place of residence and education level, were significantly associated with overall QoL. Conclusions: Slovak breast cancer survivors report moderate overall QoL, with emotional and cognitive functioning relatively preserved, but social, role and sexual domains impaired. Treatment modalities and sociodemographic factors are associated with differences in specific QoL domains, highlighting the need for targeted, context-sensitive supportive care. The findings also underscore the importance of oncology nursing in survivorship care, particularly in addressing physical, social and sexual domains and key symptoms such as insomnia, fatigue and pain. Targeted psychosocial and educational support, along with culturally sensitive QoL assessment, may help improve patient-centred outcomes in breast cancer survivors in Central and Eastern Europe.

10 June 2026 in Diseases
Verified
Journal Article
Open access
PDF file
Pavol ZuborPavol Zubor
Pavol Zubor
KLKristen Olav Lind
Kristen Olav Lind
JVJozef Visnovsky
Jozef Visnovsky
PZPetra Zubor
Petra Zubor
GGGuri Grimnes
Guri Grimnes
CKCato Kjærvik
Cato Kjærvik
Background: Pregnancy-related transient osteoporosis of the hip (PR-TOH) is an uncommon and frequently underdiagnosed condition that typically presents with acute hip pain during late pregnancy or the early postpartum period. Because its clinical presentation is nonspecific and overlaps with pregnancy-related pelvic girdle pain, the diagnosis is often delayed, and the initial management is suboptimal. Although bilateral involvement has been reported, comparative data on diagnostic work-up, multidisciplinary management, and follow-up remain limited. Case Presentation: We report a case of bilateral PR-TOH in a 35-year-old Caucasian primigravida (G1, P0) who presented at 31 + 6 weeks of gestation with progressively worsening bilateral hip pain that culminated in severe functional impairment and wheelchair dependence. Initial ultrasound, laboratory work-up, and rheumatological screening were inconclusive, and intra-articular corticosteroid injections failed to relieve symptoms and were temporally associated with deterioration of glycaemic control and a periorbital and palmar eczematous rash. Magnetic resonance imaging (MRI) demonstrated diffuse bone marrow oedema in both femoral heads with preserved articular cartilage and no evidence of avascular necrosis, supporting a diagnosis of bilateral PR-TOH. Postpartum dual-energy X-ray absorptiometry (DXA) confirmed reduced bone mineral density at both femoral necks (Z-scores below −2.0). Pregnancy was prolonged until 37 + 4 weeks, and delivery was by elective caesarean section. Postpartum care included analgesia, calcium and vitamin D supplementation, structured physiotherapy, and a graded weight-bearing rehabilitation programme. Bone mineral density improved markedly on follow-up DXA at six months, with complete clinical recovery and no further imaging abnormalities at 12, 24, and 30 months. Conclusions: PR-TOH should be considered in pregnant or postpartum women with persistent hip pain and progressive functional limitation. MRI is the key imaging modality for early diagnosis and for excluding alternative causes, whereas DXA remains the reference standard for quantifying bone mineral density and monitoring recovery. Bilateral presentations require a multidisciplinary, individualised approach that addresses both maternal and obstetric outcomes.

11 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
PZPavol Zubor
Pavol Zubor
KLKristen Olav Lind
Kristen Olav Lind
JVJozef Visnovsky
Jozef Visnovsky
PZPetra Zubor
Petra Zubor
GGGuri Grimnes
Guri Grimnes
CKCato Kjærvik
Cato Kjærvik
Background: Pregnancy-related transient osteoporosis of the hip (PR-TOH) is a rare and often underdiagnosed condition presenting with acute hip pain in late pregnancy or postpartum. Due to its nonspecific clinical presentation, it is frequently misinterpreted as common musculoskeletal or pelvic girdle pain, leading to delayed diagnosis and suboptimal management. Case Presentation: We report a rare case of bilateral PR-TOH in a 35-year-old primigravida diagnosed at 31+6 weeks of gestation. The patient presented with progressively worsening hip pain leading to severe mobility impairment. Initial investigations, including ultrasound and laboratory testing, were inconclusive. Definitive diagnosis was established by magnetic resonance imaging (MRI), demonstrating characteristic bone marrow oedema in both femoral heads. The patient was managed conservatively with analgesia, restricted weight bearing, and multidisciplinary care involving obstetrics, endocrinology, and orthopaedics. Pregnancy was successfully prolonged until 37+4 weeks, when caesarean section was performed due to clinical deterioration. Postpartum management included calcium and vitamin D supplementation and rehabilitation. Follow-up demonstrated significant improvement in bone mineral density on DEXA and complete clinical recovery at 12 months. Conclusions: PR-TOH should be considered in pregnant or postpartum women presenting with persistent hip pain and progressive functional limitation. Early use of MRI is essential for accurate diagnosis and differentiation from more common pregnancy-related conditions. Prompt recognition and multidisciplinary management are crucial to prevent complications and optimize maternal and obstetric outcomes.

13 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
PZPetra Zubor
Petra Zubor
MMMiloš Mlynček
Miloš Mlynček
JVJozef Visnovsky
Jozef Visnovsky
JBJan Bujnak
Jan Bujnak
LKLeonard Kovacik
Leonard Kovacik
Pavol ZuborPavol Zubor
Pavol Zubor
Background: Cervical and endometrial cancers remain major public health concerns, and their treatment can substantially affect quality of life (QoL) and survivorship outcomes. This study evaluated QoL among Slovak women after treatment for cervical and endometrial cancer and explored factors associated with post-treatment well-being. Methods: This cross-sectional patient-reported outcome study included 127 women: 74 with endometrial cancer and 53 with cervical cancer. Participants completed a one-time assessment using the EORTC QLQ-C30 together with the disease-specific QLQ-EN24 or QLQ-CX24 modules. Disease stages ranged from IA2 to IIIC1 in cervical cancer and IA to IIIC2ii in endometrial cancer. Eligible participants had histologically confirmed malignancy, ECOG 1–2, and had completed primary treatment 6–60 months before assessment. Analyses included Mann–Whitney U tests, Friedman’s ANOVA, and exploratory multiple linear regression; p-values were interpreted as nominal. Results: The mean age was 57.6 years for endometrial and 49.1 years for cervical cancer patients. All patients underwent surgery; 41.7% received no adjuvant chemotherapy or radiotherapy, 8.7% received adjuvant chemotherapy alone, 24.4% radiotherapy alone, and 25.2% combined chemoradiotherapy. In cervical cancer, cognitive and emotional functioning were relatively preserved, while fatigue, financial difficulties, and sexual/vaginal problems were prominent. In endometrial cancer, cognitive and physical functioning were relatively preserved, whereas social functioning was lower and insomnia and fatigue were frequently reported. Exploratory unadjusted treatment comparisons showed lower global health/QoL among endometrial cancer patients exposed to chemotherapy (r_rb = −0.688, 95% CI −0.950 to −0.387, p < 0.001), whereas radiotherapy exposure was associated with lower cognitive functioning (r_rb = −0.332, 95% CI −0.556 to −0.096, p = 0.008) and higher lymphoedema scores (r_rb = 0.357, 95% CI 0.118 to 0.581, p = 0.005). Cervical cancer treatment comparisons showed mixed, bidirectional symptom associations. In multivariable analyses, the cervical cancer model showed an adjusted R2 of 0.406; increasing age (B = −1.545, 95% CI −2.406 to −0.683, p < 0.001), higher education level (B = −21.706, 95% CI −37.018 to −6.393, p = 0.006), and chemotherapy exposure (B = −43.431, 95% CI −63.459 to −23.403, p < 0.001) were inversely associated with global health/QoL, whereas radiotherapy showed a positive association (B = 46.694, 95% CI 25.199 to 68.189, p < 0.001). In endometrial cancer, chemotherapy (B = −15.121, 95% CI −22.580 to −7.663, p < 0.001) and radiotherapy (B = −7.360, 95% CI −13.715 to −1.005, p = 0.024) were inversely associated with global health/QoL, while rural residence showed a positive association (B = 7.186, 95% CI 0.460 to 13.913, p = 0.037); age was not significantly associated with QoL. These findings remain exploratory and should not be interpreted as causal treatment effects. Conclusions: Women assessed 6–60 months after treatment reported difficulties particularly in fatigue, social functioning, and sexual-health domains. Treatment-related associations should be interpreted cautiously because of treatment-group heterogeneity, potential confounding by indication, and multiple testing. These preliminary findings support further evaluation of survivorship needs related to symptom management, psychosocial support, sexual health, and long-term QoL.